Search hospitals > District of Columbia > Washington
George Washington University Medical Center
Claim this profileWashington, District of Columbia 20037
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Cancer
Conducts research for Infections
Conducts research for Coronavirus
Conducts research for Kidney Failure
188 reported clinical trials
33 medical researchers
Summary
George Washington University Medical Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Human Immunodeficiency Virus Infection, Cancer, Infections, Coronavirus, Kidney Failure and other specialties. George Washington University Medical Center is involved with conducting 188 clinical trials across 456 conditions. There are 33 research doctors associated with this hospital, such as Pavani Chalasani, Julie Bauman, MD, Mardi Gomberg-Maitland, MD, and Andrew Meltzer, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global Leader2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Pavani ChalasaniUniversity of Arizona Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Peripheral Neuropathy
15 reported clinical trials
31 drugs studied
Julie Bauman, MDGeorge Washington University Medical Center5 years of reported clinical research
Studies Cancer
Studies Oral Squamous Cell Carcinoma
7 reported clinical trials
12 drugs studied
Mardi Gomberg-Maitland, MDThe George Washington University Medical Faculty Associates3 years of reported clinical research
Studies Pulmonary Hypertension
Studies High Blood Pressure
5 reported clinical trials
6 drugs studied
Andrew Meltzer, MDGeorge Washington University Hospital1 year of reported clinical research
Studies Coronavirus
Studies Upper Gastrointestinal Bleeding
5 reported clinical trials
8 drugs studied
Clinical Trials running at George Washington University Medical Center
Prostate Cancer
Squamous Cell Carcinoma
Cancer
Rectal Cancer
Lung Cancer
Anal Cancer
Oropharyngeal Carcinoma
Ovarian Cancer
Fallopian Tube Cancer
Breast Cancer
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Apalutamide
for Prostate Cancer
Apalutamide is an anti-androgen that blocks the effect of testosterone on prostate cancer growth. This phase IIa trial is designed to determine whether very low doses of apalutamide, given for 3 to 4 weeks before prostate surgery to men with prostate cancer confined to the prostate gland, reduces plasma levels of PSA (a biomarker of apalutamide's ability to block testosterone). If low dose apalutamide lowers PSA levels in this setting, further study of this agent in men with localized prostate cancer who wish to delay definitive therapy with surgery or radiation may be warranted.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at George Washington University Medical Center?
George Washington University Medical Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Human Immunodeficiency Virus Infection, Cancer, Infections, Coronavirus, Kidney Failure and other specialties. George Washington University Medical Center is involved with conducting 188 clinical trials across 456 conditions. There are 33 research doctors associated with this hospital, such as Pavani Chalasani, Julie Bauman, MD, Mardi Gomberg-Maitland, MD, and Andrew Meltzer, MD.